Corbus Pharmaceuticals’ (CRBP) Buy Rating Reiterated at HC Wainwright
otakuyassine3@gmail.com HC Wainwright reaffirmed their buy rating on shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report)...
Wainwright
HC Wainwright Reiterates Buy Rating for Prothena (NASDAQ:PRTA)
Prothena (NASDAQ:PRTA – Get Free Report)‘s stock had its “buy” rating restated by equities researchers...
CRISPR Therapeutics (NASDAQ:CRSP) Given “Buy” Rating at HC Wainwright
CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities...
Vericel (NASDAQ:VCEL) Given “Buy” Rating at HC Wainwright
Vericel (NASDAQ:VCEL – Get Free Report)‘s stock had its “buy” rating restated by equities research...
Vir Biotechnology (NASDAQ:VIR) Earns “Buy” Rating from HC Wainwright
Vir Biotechnology (NASDAQ:VIR – Get Free Report)‘s stock had its “buy” rating reissued by equities...
Rhythm Pharmaceuticals’ (RYTM) Buy Rating Reaffirmed at HC Wainwright
Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Free Report)‘s stock had its “buy” rating restated by analysts...
HC Wainwright Comments on Arvinas’ Q3 Earnings (NASDAQ:ARVN)
Arvinas, Inc. (NASDAQ:ARVN – Free Report) – Investment analysts at HC Wainwright issued their Q3...